Apr 18, 2022 / 11:00PM GMT
Unidentified Company Representative -
All right. I think that's everybody. So good morning. Thank you for joining Volpara's Q4 FY '22 Update Call. Joining us today is Group CEO, Ralph Highnam; Jill Spear, Executive Vice President of Sales and Marketing; Chief Financial Officer, Craig Hadfield; and Teri Thomas, Strategic Adviser. (Operator Instructions) I would also like to remind you that today's call is being recorded.
So I'll now hand over to Group CEO, Ralph Highnam.
Ralph Highnam - Volpara Health Technologies Limited - MD, Chief Scientist, CEO & Director
Thanks, [Lauren]. Hello, and thank you for your taking the time this morning to hear about our busy and commercially strong Q4 FY 2022, which ended the 31st of March 2022.
Volpara's mission is to save families from cancer by providing an integrated software platform for the delivery of personalized breast care. We're proud that our software is now contracted to be used in over 35% of the U.S. breast cancer screenings. That software is helping ensure that patient experience is personalized,
Q4 2022 Volpara Health Technologies Ltd Activities Report Call Transcript
Apr 19, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers